Skip to main content
. 2018 Oct 6;8(18):5106–5125. doi: 10.7150/thno.26585

Figure 1.

Figure 1

HER2(+) tumor surface-bound anti-HER2-C825 BsAb is rapidly internalized. Anti-HER2-C825 was radioiodinated and in vitro radiotracer binding studies were performed with HER2(+) BT-474 cells to determine the internalization and cellular processing at 37 °C of 131I-anti-HER2-C825. Data is presented as mean ± standard deviation (SD) (n = 3).